EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nuclear envelope proteins in cancer: revisiting the significance of LEM-domain proteins

Amie Jobe, Sameer Mirza, Ranjit Vijayan

Frontiers in Cell and Developmental Biology · 22.04.2026 · 14

DOI: 10.3389/fcell.2026.1789623 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 22.04.2026. Verfasst von Amie Jobe und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear envelope dysfunction is increasingly recognized as a driver of cancer-associated alterations in chromatin organization, genome stability, and mechanotransduction. Among inner nuclear membrane components are the LEM-domain (LEM-D) proteins LAP2/TMPO, emerin (EMD), LEMD1, LEMD2, MAN1/LEMD3, ANKLE1, and ANKLE2. Accumulating evidence links dysregulation of these proteins to hallmark cancer processes, including cell-cycle control, epithelial–mesenchymal transition, genome instability, and therapeutic resistance. This review synthesizes recent mechanistic and translational findings on LEM-D proteins in cancer, highlighting isoform-specific functions, context-dependent oncogenic versus tumor-suppressive roles, and convergence on key pathways such as Wnt/β-catenin, PI3K/AKT, MAPK, and TGF-β signaling. Concrete evidence for prognostic value varies across the LEM-D proteins. While much of the current evidence derives from transcript-level and preclinical studies, emerging data suggest that LEM-D proteins contribute to nuclear stress adaptation and may represent context-dependent therapeutic vulnerabilities. We discuss their prognostic and predictive potential, critically evaluate limitations in current datasets, and present a unifying framework linking LEM-D dysfunction to genome instability, altered signalling, and therapy resistance. Thus, despite growing evidence of therapeutic potential, these proteins are better positioned as biomarkers to guide current therapies.

Schlagwörter

Stichwörter der Autor:innen

LEM-domain proteinsbiomarkercancernuclear envelope proteinsnucleus

Autor:innen und Institutionen

  • Department of Biology, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Department of Chemistry, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Zayed Center for Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Zitieren

APA

Jobe, A., Mirza, S., & Vijayan, R. (2026). Nuclear envelope proteins in cancer: revisiting the significance of LEM-domain proteins. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1789623

Vancouver

Jobe A, Mirza S, Vijayan R. Nuclear envelope proteins in cancer: revisiting the significance of LEM-domain proteins. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1789623

BibTeX
@article{Jobe2026,
  author = {Jobe, Amie and Mirza, Sameer and Vijayan, Ranjit},
  title = {Nuclear envelope proteins in cancer: revisiting the significance of LEM-domain proteins},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1789623}
}
Kostenlos starten →